30th June 2022 | Pharma Updates
Innova Captab submits preliminary IPO funding documents to Sebi
Innova Captab Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). The proposed IPO would involve the issuance of new equity shares worth Rs 400 crore.
Novo Nordisk announces innovative plans for treating rare blood disorders
Novo Nordisk will reveal new data in the treatment of rare diseases at the International Society on Thrombosis and Haemostasis 2022 Congress, which will be held in London next month.
Leprosy patients soon have access to a physiotherapy centre in Indore
The district health authorities are establishing a physiotherapy centre for leprosy patients in the multi-story Palika plaza, which houses health department offices. The new centre will provide pre- and post-surgery care to leprosy patients with grade two deformities.
Johnson & Johnson updates its 'Positively Fearless' HIV campaign
Johnson & Johnson is expanding its “Positively Fearless” HIV campaign in order to break the old stigma associated with the disease while also expanding its outreach into the LGBTQ+ community.
NTAGI recommends cervical cancer and Typhoid vaccinations
After reviewing the data, the government advisory panel NTAGI is said to have recommended vaccination against cervical cancer and typhoid on Tuesday.
Sanofi receives two European approvals for enzyme replacement therapies for rare diseases
Sanofi announced two European Commission approvals for enzyme replacement therapies for rare diseases on Tuesday morning. The first is for Xenpoxyme, and the second is for Nexviadyme.
Beyond Air LungFit PH approved by USFDA to treat hypoxic respiratory failure
FDA has approved Beyond Air’s LungFit PH system for the treatment of hypoxic respiratory failure in term and near-term neonates. The device employs the company’s Ionizer technology to generate unlimited, on-demand nitric oxide from ambient air.